Review • Journal • PD(L)-1 Biomarker • IO biomarker • Metastases
|
EGFR (Epidermal growth factor receptor) • HER-2 (Human epidermal growth factor receptor 2) • PD-L1 (Programmed death ligand 1) • KRAS (KRAS proto-oncogene GTPase) • BRAF (B-raf proto-oncogene) • ALK (Anaplastic lymphoma kinase) • RET (Ret Proto-Oncogene) • ROS1 (Proto-Oncogene Tyrosine-Protein Kinase ROS) • NTRK (Neurotrophic receptor tyrosine kinase)
|
BRAF V600E • KRAS mutation • EGFR mutation • PD-L1 overexpression • KRAS G12C • BRAF V600 • EGFR T790M • RET fusion • EGFR exon 20 insertion • EGFR expression • EGFR overexpression • MET exon 14 mutation • RET mutation • ROS1 fusion • EGFR exon 20 mutation
|
Keytruda (pembrolizumab) • Tagrisso (osimertinib) • Enhertu (fam-trastuzumab deruxtecan-nxki) • Lumakras (sotorasib) • Krazati (adagrasib) • Tepmetko (tepotinib) • Tabrecta (capmatinib)